CARDIOVASCULAR RISK FEATURES IN PATIENTS WITH METABOLIC-ASSOCIATED FATTY LIVER DISEASE (MAFLD) DEPENDING ON THE PRESENCE OF OBESITY. ijms [Internet]. 2025 Jun. 3 [cited 2026 Aug. 7];5(05):396-403. Available from: https://www.academicpublishers.org/journals/index.php/ijms/article/view/4890